Jpmorgan Chase & CO Edwards Lifesciences Corp Transaction History

Jpmorgan Chase & CO

$1.23 Trillion
Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 14,851,827 shares of EW stock, worth $1.08 Billion. This represents 0.09% of its overall portfolio holdings.

Number of Shares

14,851,827

Previous 8,466,048 75.43%

Holding current value

$1.08 Billion

Previous $559 Million 96.8%

% of portfolio

0.09%

Previous 0.05%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$64.54 - $75.92 $412 Million - $485 Million	6,385,779 Added 75.43%	14,851,827 $1.1 Billion
Q3 2024 Dec 26, 2024	SELL	$59.7 - $93.78 $12.7 Million - $20 Million	-212,869 Reduced 2.45%	8,466,048 $559 Million
Q3 2024 Nov 08, 2024	SELL	$59.7 - $93.78 $9.24 Million - $14.5 Million	-154,792 Reduced 1.8%	8,466,048 $559 Million
Q2 2024 Dec 26, 2024	BUY	$84.3 - $94.31 $17.9 Million - $20.1 Million	212,869 Added 2.51%	8,678,917 $802 Million
Q2 2024 Aug 12, 2024	SELL	$84.3 - $94.31 $80.3 Million - $89.9 Million	-953,010 Reduced 9.95%	8,620,840 $796 Million
Q1 2024 Dec 26, 2024	BUY	$72.54 - $95.56 $82.3 Million - $108 Million	1,135,008 Added 13.41%	9,601,056 $917 Million
Q1 2024 May 10, 2024	BUY	$72.54 - $95.56 $130 Million - $171 Million	1,790,783 Added 23.01%	9,573,850 $915 Million
Q4 2023 Dec 26, 2024	SELL	$61.71 - $77.76 $39.2 Million - $49.4 Million	-635,383 Reduced 7.51%	7,830,665 $597 Million
Q4 2023 Feb 12, 2024	BUY	$61.71 - $77.76 $264 Million - $333 Million	4,285,357 Added 122.52%	7,783,067 $593 Million
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $22 Million - $29.6 Million	317,229 Added 9.97%	3,497,710 $242 Million
Q2 2023 Aug 11, 2023	BUY	$81.41 - $94.33 $62.5 Million - $72.4 Million	767,847 Added 31.83%	3,180,481 $300 Million
Q1 2023 May 18, 2023	BUY	$74.26 - $84.51 $21.6 Million - $24.6 Million	290,979 Added 13.71%	2,412,634 $200 Million
Q1 2023 May 11, 2023	BUY	$74.26 - $84.51 $22 Million - $25.1 Million	296,482 Added 16.24%	2,121,655 $176 Million
Q4 2022 Feb 13, 2023	SELL	$68.3 - $87.44 $13.4 Million - $17.2 Million	-196,581 Reduced 9.72%	1,825,173 $136 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $4.15 Million - $5.41 Million	50,418 Added 2.56%	2,021,754 $167 Million
Q2 2022 Aug 11, 2022	BUY	$86.5 - $128.27 $58.1 Million - $86.1 Million	671,264 Added 51.63%	1,971,336 $187 Million
Q1 2022 May 11, 2022	BUY	$101.96 - $128.34 $20.3 Million - $25.6 Million	199,094 Added 18.08%	1,300,072 $153 Million
Q4 2021 Feb 10, 2022	SELL	$106.37 - $130.68 $1.14 Million - $1.4 Million	-10,693 Reduced 0.96%	1,100,978 $143 Million
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $114 Million - $136 Million	1,111,671 New	1,111,671 $126 Million

Others Institutions Holding EW

# of Institutions

1,382

Shares Held

487M

Call Options Held

6.71M

Put Options Held

3.17M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Edwards Lifesciences Corp Transaction History